One step closer to understanding atherosclerosis
Dr Ashish Misra published a review that brings us one step closer to understanding the inner workings of atherosclerosis, the major cause of stroke and heart attack.
Link between dementia and atrial fibrillation (irregular heartbeat)
A major new report, led by HRI's Prof Ben Freedman, has confirmed a strong link between atrial fibrillation (irregular heartbeat) and dementia.
Prof Roland Stocker awarded 2021 Basic Science Award
Professor Roland Stocker, leader of the Arterial Inflammation and Redox Biology Group at HRI, has been awarded the 2021 Basic Science Award from the esteemed Society for Free Radical Research-Europe.
New hope for babies born with heart defect
Dr Ashish Misra is conducting research that opens a pathway towards a improved therapy for patients with the heart defect SVAS.
First congenital heart disease registry launched in Australia
In an Australian first, doctors have developed the Australian New Zealand Congenital Heart Disease Registry to help improve the lives of people living with the condition, and their families.
A pioneering generation: people with complex congenital heart disease living longer
People born with half a heart or single-ventricle congenital heart disease (Fontan-CHD) are now living longer than ever before, thanks to advances in medicine and technology.
HRI awards grants for NZ collaborations
HRI is delighted to announce the award of three grants funded by HRI donors to support research into cardiovascular disease – the world’s biggest killer.
Arterial Inflammation and Redox Biology Group publishes in Nature Communications
The Arterial Inflammation and Redox Biology Group, led by Professor Roland Stocker, has published a paper in the prestigious Nature Communications journal.
HRI wins Silver in PRIA Golden Target Awards
A fundraising appeal by the Heart Research Institute (HRI) has won silver in the Golden Target Awards, run by the Public Relations Institute of Australia (PRIA).